Co-Targeting HSP90 Alpha and CDK7 Overcomes Resistance against HSP90 Inhibitors in BCR-ABL1+ Leukemia Cells

Investigators found that the absence of HSP90α caused downregulation of CD45 expression and restricted in vivo growth of BCR-ABL1+ leukemia cells.